Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06075368 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Efficacy and Safety of GENOSS® SES in Patients With Acute Coronary Syndrome (GENOSS ACS)

Study acronym: GENOSS ACS
StatusActive, Not Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study Identification, Study Status, Oversightv4
  2. Trial status: Recruiting to Active, Not Recruiting Enrollment target: estimated 1000 to confirmed 757 · Completion date: Dec 31, 2025 to Dec 31, 2027 · Start date: Feb 17, 2020 to Mar 16, 2020 · 8 morev3 Show 11 more changesShow less
    • Enrollment target: estimated 1000 to confirmed 757
    • Completion date: Dec 31, 2025 to Dec 31, 2027
    • Start date: Feb 17, 2020 to Mar 16, 2020
    • Interventions: Genoss DES (Device) to GENOSS Sirolimus Eluting Coronary Stent System (Device)
    • Eligibility criteria expanded, about 106 words
    • Secondary endpoints: 1 to 9
    • Primary endpoint revised
    • Study description expanded, about 30 words
    • Site details revised
    • Study arms: 0 to 1
    • Study title expanded, about 2 words

    See this version in full on ClinicalTrials.gov ↗

  3. Eligibility criteria shortened, about 4 words Study title expanded, about 1 wordv2 Show 1 more changeShow less
    • Study title expanded, about 1 word

    See this version in full on ClinicalTrials.gov ↗

  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The objective of this study is to evaluate the efficacy and safety of the GENOSS SES in patients with acute coronary syndrome (ACS) in real-world pratice.
Trial Details
NCT Number NCT06075368
Lead Sponsor Genoss Co., Ltd.
Conditions Acute Coronary Syndrome, Percutaneous Coronary Intervention
Enrollment 757 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov